|By Marketwired .||
|June 13, 2014 07:35 PM EDT||
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/13/14 -- BioAB Strategies Ltd. (the "Company") is pleased to announce that it has closed its previously announced non-brokered financing (the "Financing") and has issued a total of 5,000,000 units (the "Units") for aggregate proceeds of $200,000, at a price of $0.04 per Unit. Each Unit is comprised of one common share and one share purchase warrants, exercisable to purchase one common share for one year at a price of $0.06.
The proceeds from the Financing will be used for working capital requirements and to develop the Company's business plan.
BioAB Strategies Ltd. is a private Canadian bio-pharmaceutical reporting issuer which holds a licensed patent portfolio.
Chief Executive Officer
Chief Financial Officer & Director